543 related articles for article (PubMed ID: 29377001)
1. Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.
Yin H; Song CQ; Suresh S; Kwan SY; Wu Q; Walsh S; Ding J; Bogorad RL; Zhu LJ; Wolfe SA; Koteliansky V; Xue W; Langer R; Anderson DG
Nat Chem Biol; 2018 Mar; 14(3):311-316. PubMed ID: 29377001
[TBL] [Abstract][Full Text] [Related]
2. Chimeric DNA-RNA Guide RNA Designs.
Lu S; Zhang Y; Yin H
Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
[TBL] [Abstract][Full Text] [Related]
3. Specificity profiling of CRISPR system reveals greatly enhanced off-target gene editing.
Wang Y; Wang M; Zheng T; Hou Y; Zhang P; Tang T; Wei J; Du Q
Sci Rep; 2020 Feb; 10(1):2269. PubMed ID: 32042045
[TBL] [Abstract][Full Text] [Related]
4. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
5. Harnessing noncanonical crRNA for highly efficient genome editing.
Xun G; Zhu Z; Singh N; Lu J; Jain PK; Zhao H
Nat Commun; 2024 May; 15(1):3823. PubMed ID: 38714643
[TBL] [Abstract][Full Text] [Related]
6. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
7. Efficient Single-Nucleotide Microbial Genome Editing Achieved Using CRISPR/Cpf1 with Maximally 3'-End-Truncated crRNAs.
Lee HJ; Kim HJ; Park YJ; Lee SJ
ACS Synth Biol; 2022 Jun; 11(6):2134-2143. PubMed ID: 35584409
[TBL] [Abstract][Full Text] [Related]
8. Engineering Introns to Express RNA Guides for Cas9- and Cpf1-Mediated Multiplex Genome Editing.
Ding D; Chen K; Chen Y; Li H; Xie K
Mol Plant; 2018 Apr; 11(4):542-552. PubMed ID: 29462720
[TBL] [Abstract][Full Text] [Related]
9. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
11. Improving Stability and Specificity of CRISPR/Cas9 System by Selective Modification of Guide RNAs with 2'-fluoro and Locked Nucleic Acid Nucleotides.
Sakovina L; Vokhtantsev I; Vorobyeva M; Vorobyev P; Novopashina D
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362256
[TBL] [Abstract][Full Text] [Related]
12. CRISPR RNA Array-Guided Multisite Cleavage for Gene Disruption by Cas9 and Cpf1.
Wang D; Ma D; Han J; Kong L; Li LY; Xi Z
Chembiochem; 2018 Oct; 19(20):2195-2205. PubMed ID: 30088313
[TBL] [Abstract][Full Text] [Related]
13. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
[TBL] [Abstract][Full Text] [Related]
14. Aptazyme-mediated direct modulation of post-transcriptional sgRNA level for conditional genome editing and gene expression.
Chen H; Li Y; Du C; Li Y; Zhao J; Zheng X; Mao Q; Xia H
J Biotechnol; 2018 Dec; 288():23-29. PubMed ID: 30391232
[TBL] [Abstract][Full Text] [Related]
15. Mismatch Intolerance of 5'-Truncated sgRNAs in CRISPR/Cas9 Enables Efficient Microbial Single-Base Genome Editing.
Lee HJ; Kim HJ; Lee SJ
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208669
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3'-overhang.
Bin Moon S; Lee JM; Kang JG; Lee NE; Ha DI; Kim DY; Kim SH; Yoo K; Kim D; Ko JH; Kim YS
Nat Commun; 2018 Sep; 9(1):3651. PubMed ID: 30194297
[TBL] [Abstract][Full Text] [Related]
17. Design and Evaluation of Guide RNA Transcripts with a 3'-Terminal HDV Ribozyme to Enhance CRISPR-Based Gene Inactivation.
Berkhout B; Gao Z; Herrera-Carrillo E
Methods Mol Biol; 2021; 2167():205-224. PubMed ID: 32712922
[TBL] [Abstract][Full Text] [Related]
18. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
19. Core Hairpin Structure of SpCas9 sgRNA Functions in a Sequence- and Spatial Conformation-Dependent Manner.
Jiang M; Ye Y; Li J
SLAS Technol; 2021 Feb; 26(1):92-102. PubMed ID: 32486929
[TBL] [Abstract][Full Text] [Related]
20. Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.
Rose JC; Popp NA; Richardson CD; Stephany JJ; Mathieu J; Wei CT; Corn JE; Maly DJ; Fowler DM
Nat Commun; 2020 Jun; 11(1):2697. PubMed ID: 32483117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
